EXACT SCIENCES CORP (EXAS) Current Deferred Revenue (2010 - 2013)

Exact Sciences (EXAS) has reported Current Deferred Revenue for 4 consecutive years, with $294000.0 the latest figure, recorded in Q4 2013.

• On a quarterly basis, Current Deferred Revenue fell 92.9% year-over-year to $294000.0 in Q4 2013; TTM through Dec 2013 was $294000.0, a 92.9% decrease from a year earlier, with the FY2013 full-year figure at $294000.0, down 92.9% from the prior year.
• Current Deferred Revenue was $294000.0 for Q4 2013 at Exact Sciences, down from $1.3 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $4.1 million in Q4 2010 and troughed at $294000.0 in Q4 2013.
• A 4-year average of $3.4 million and a median of $4.1 million in 2010 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue changed 0.0% in 2011 and tumbled 92.9% in 2013, its largest moves.
• Over 4 years, Current Deferred Revenue stood at $4.1 million in 2010, then changed by 0.0% to $4.1 million in 2011, then changed by 0.0% to $4.1 million in 2012, then plunged by 92.9% to $294000.0 in 2013.
• The last three Current Deferred Revenue figures came in at $294000.0 (Q4 2013), $1.3 million (Q3 2013), and $2.4 million (Q2 2013), per Business Quant data.